<DOC>
	<DOCNO>NCT02778698</DOCNO>
	<brief_summary>This expand access protocol child get enough nutrient food must receive nutrition vein . The standard nutrition give vein blend soybean fat . If give long period time , cause problem . It lead severe and/or permanent injury liver . It believe type fish oil blend , call Omegaven® , may use place soybean fat blend . The Omegaven® fish oil blend may greatly reduce risk liver injury . Omegaven® approve Food Drug Administration ( FDA ) . It offer `` expanded access '' protocol alternative soybean fat blend .</brief_summary>
	<brief_title>Compassionate Use Omegaven</brief_title>
	<detailed_description />
	<mesh_term>Cholestasis</mesh_term>
	<criteria>1 . Male female 2 . Older 14 day less 5 year age 3 . Direct bilirubin value great 2 mg/dL 4 . Be expect require intravenous nutrition least additional 28 day 5 . Parent/legal guardian agree provide consent/parental permission 1 . Patients congenitally lethal condition ( e.g . Trisomy 13 ) . 2 . Patients clinically severe bleed able manage routine measure . 3 . Patients evidence viral hepatitis primary liver disease primary etiology cholestasis . 4 . Patients health problem survival extremely unlikely even infant 's cholestasis improve . 5 The parent/legal guardian unwilling provide consent/parental permission .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>